Scientific work

Doç. Dr. Doğan Yazılıtaş

101 publications. The source of the information is stated next to each publication.

Back to profile

  1. ACCESSORY SPLEEN HYPERTROPHY MIMICKING COLON CANCER METASTASIS

    Experimental Oncology, 2016

    DOI 10.31768/2312-8852.2016.38(3):202-203 PMID 27685531 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  2. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-4359-1 PMID 26553363 13 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Mide Kanserinde Tanı Anındaki Evre ile Patolojik Alt Tip ve Lokalizasyonun İlişkisi

    2015

    Source: OpenAlex

  4. Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.

    Breast (Edinburgh, Scotland), 2015

    DOI 10.1016/j.breast.2015.11.006 PMID 26801412 23 citations (Europe PMC) Source: ORCID

  5. Treatment approaches in 102 elderly patients with non-small cell lung cancer

    CJAM Canadian Journal of Addiction Medicine, 2015

    DOI 10.14740/wjon894w PMID 29147416 Open-access full textSource: ORCID

  6. 3238 The effect of “international prognostic index (IPI)” in the determination of prognosis of early stage diffuse large b cell non-hodgkin lymphoma: Is it enough?

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31815-9 Source: OpenAlex

  7. 2395 The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fiuorouracil (mDCF) regimen

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31311-9 Source: OpenAlex

  8. doctor

    2015

    Source: ORCID

  9. A retrospective comparison of early stage primary extranodal with nodal non-Hodgkin lymphoma patients: A single center experience

    Journal of B.U.ON., 2015

    PMID 26854450 3 citations (OpenAlex) Source: ORCID

  10. Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.11.4777 PMID 26107239 Open-access full textSource: ORCID

  11. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer

    Annals of Nuclear Medicine, 2015

    DOI 10.1007/s12149-015-0985-3 PMID 26008856 6 citations (Europe PMC) Source: ORCID

  12. Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.4.1471 PMID 25743817 2 citations (Europe PMC) Open-access full textSource: ORCID

  13. Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-3728-0 PMID 26150339 5 citations (Europe PMC) Open-access full textSource: ORCID

  14. Rectal Cancer With Metastasis to the Face

    UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2015

    DOI 10.4999/uhod.15903 2 citations (OpenAlex) Open-access full textSource: ORCID

  15. Adjuvant Therapy in Patients with Gallbladder Carcinoma

    Journal of Gastroenterology and Hepatology Research, 2015

    DOI 10.17554/j.issn.2224-3992.2015.04.484 Open-access full textSource: OpenAlex

  16. 2350 The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31266-7 Source: OpenAlex

  17. 3223 The comparison of early stage primary nodal and extranodal diffuse large cell lymphomas: Clinical features, treatment and survival outcomes

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31800-7 Source: OpenAlex

  18. Factors of early recurrence (

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12066 Source: OpenAlex

  19. Breast cancer subtypes and the risk of distant relapse after breast conserving surgery or mastectomy: An Anatolian Society of Medical Oncology study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12052 Open-access full textSource: OpenAlex

  20. Breast cancer subtypes and the risk of distant relapse after breast conserving surgery or mastectomy: An Anatolian Society of Medical Oncology study.

    Bursa Uludag University - AVESIS, 2015

    Source: OpenAlex

  21. THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX IPI IN THEDETERMINATION OF PROGNOSIS OF EARLY STAGE DIFFUSE LARGE B CELLNON HODGKIN LYMPHOMA IS IT ENOUGH

    AYBU AVESIS, 2015

    Source: OpenAlex

  22. Factors of early recurrence ( 24 months) in relapsed node negative early stage breast cancer (the study of Anatolian Society of Medical Oncology).

    Bursa Uludag University - AVESIS, 2015

    Source: OpenAlex

  23. The ef cacy and predictive factors of response of second line triplet modi ed EOX epirubicin oxaliplatin capacitabine regimen in metastatic gastric cancer

    AYBU AVESIS, 2015

    Source: OpenAlex

  24. The effect of body mass index in patients with relapsed colorectal cancer

    AYBU AVESIS, 2015

    Source: OpenAlex

  25. The importance of thiol disulphide homeostasis in patients with advanced gastric cancer AGC receiving modi ed docetaxel and cisplatin plus uorouracil mDCF regimen

    AYBU AVESIS, 2015

    Source: OpenAlex

  26. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0929-0 PMID 24659267 4 citations (Europe PMC) Source: ORCID

  27. Recurrence risk and prognostic parameters in stage I rectal cancers

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.13.5337 PMID 25040998 1 citation (Europe PMC) Open-access full textSource: ORCID

  28. Morphine: Patient Knowledge and Attitudes in the Central Anatolia Part of Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.12.4983 PMID 24998575 13 citations (OpenAlex) Open-access full textSource: OpenAlex

  29. Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0153-y PMID 25099765 1 citation (Europe PMC) Source: ORCID

  30. EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu327.44 Open-access full textSource: ORCID

  31. Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin's Lymphoma: a Single Institute Experience

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.20.8715 PMID 25374196 4 citations (Europe PMC) Open-access full textSource: ORCID

  32. XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.23.10375 PMID 25556478 4 citations (Europe PMC) Open-access full textSource: ORCID

  33. Nadir Görülen Sarkom Türleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2014

    Source: OpenAlex

  34. Metastatik safra kesesi kanserinde kemoterapinin yeri: Retrospektif değerlendirme

    Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi, 2014

    DOI 10.7197/cmj.v36i4.5000071499 Open-access full textSource: OpenAlex

  35. Comparison the Efficacy of Second Line Eox and Folfiri Regimens in Metastatic Gastric Cancer

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu334.66 Open-access full textSource: OpenAlex

  36. Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e11542 Open-access full textSource: OpenAlex

  37. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

    Oncology Letters, 2013

    DOI 10.3892/ol.2013.1408 PMID 24137379 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  38. Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

    Karger Kompass Onkologi, 2013

    DOI 10.1159/000355156 PMID 24107908 3 citations (Europe PMC) Source: ORCID

  39. Biologic subtypes and first relapse pattern in curative surgery performed breast cancer patients: Study of Anatolian Society of Medical Oncology.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e11559 1 citation (OpenAlex) Source: OpenAlex

  40. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178571 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  41. Retrospective analysis of 178 patients with stage I rectum cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14662 Open-access full textSource: OpenAlex

  42. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178570 Open-access full textSource: OpenAlex

  43. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178568 Source: OpenAlex

  44. PharmaNews

    Onkologie, 2013

    DOI 10.1159/000178589 Open-access full textSource: OpenAlex

  45. PharmaForum

    Onkologie, 2013

    DOI 10.1159/000178587 Open-access full textSource: OpenAlex

  46. Imprint

    Onkologie, 2013

    DOI 10.1159/000178608 Source: OpenAlex

  47. Meetings and Conferences · Tagungen und Kongresse

    Onkologie, 2013

    DOI 10.1159/000178596 Open-access full textSource: OpenAlex

  48. Mitteilungen onkologischer Gesellschaften · Reports of Oncological Societies

    Onkologie, 2013

    DOI 10.1159/000178597 Open-access full textSource: OpenAlex

  49. PharmaNews

    Onkologie, 2013

    DOI 10.1159/000178588 Source: OpenAlex

  50. Biologic subtypes and first relapse pattern in curative surgery performed breast cancer patients: Study of Anatolian Society of Medical Oncology.

    Bursa Uludag University - AVESIS, 2013

    Source: OpenAlex